Novel insights into the distribution and functional aspects of the calcium binding protein Secretagogin from studies on rat brain and primary neuronal cell culture

Frontiers in Molecular Neuroscience

Volumn , Issue AUG 2012, 2012, Pages

  Maj, Magdalena ^a   Milenkovic, Ivan ^a,b   Bauer, Jan ^a   Berggård, Tord ^c   Veit, Martina ^a   Ilhan Mutlu, Aysegül ^a   Wagner, Ludwig ^a   Tretter, Verena ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Alligator Bioscience   (Sweden)

Author keywords

Calcium binding proteins; Insulin; Neuronal cell marker; Secretagogin

Indexed keywords

CALBINDIN; CALCIUM; CALCIUM BINDING PROTEIN; CALRETININ; GLUCOSE; INSULIN; PARVALBUMIN; SECRETAGOGIN PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; BRAIN SLICE; BRAIN TISSUE; CELL CULTURE; CELL DENSITY; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CYTOSOL; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULINOMA; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; MOLECULAR MECHANICS; NONHUMAN; PANCREAS ISLET BETA CELL; PROCESS MODEL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; TUMOR CELL;

EID: 84865106489     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00084     Document Type: Article

References (42)

1. Adolf, K., Wagner, L., Bergh, A., Stattin, P., Ottosen, P., Borre, M., Birkenkamp-Demtroder, K., Orntoft, T. F., and Torring, N. (2007). Secretagogin is a new neuroendocrine marker in the human prostate. Prostate 67, 472-484.
2. Attems, J., Ittner, A., Jellinger, K., Nitsch, R. M., Maj, M., Wagner, L., Gotz, J., and Heikenwalder, M. (2011). Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice. J. Neural Transm. 118, 737-745.
3. Attems, J., and Jellinger, K. A. (2006). Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin. Neuropathol. 25, 265-271.
4. Attems, J., Preusser, M., Grosinger-Quass, M., Wagner, L., Lintner, F., and Jellinger, K.(2008). Calcium-bindingprotein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 34, 23-32.
5. Attems, J., Quass, M., Gartner, W., Nabokikh, A., Wagner, L., Steurer, S., Arbes, S., Lintner, F., and Jellinger, K. (2007). Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons. Exp. Gerontol. 42, 215-222.
6. Baskin, D. G., Figlewicz, D. P., Woods, S. C., Porte, D. Jr., and Dorsa, D. M. (1987). Insulin in the brain. Annu. Rev. Physiol. 49, 335-347.
7. Bauer, M., Maj, M., Wagner, L., Cahill, D. J., Linse, S., and O'Connell, D. J. (2011a). Protein networks involved in vesicle fusion, transport, and storage revealed by array-based proteomics. Methods Mol. Biol. 781, 47-58.
8. Bauer, M. C., O'Connell, D. J., Maj, M., Wagner, L., Cahill, D. J., and Linse, S. (2011b). Identification of a highaffinity network of secretagoginbinding proteins involved in vesicle secretion. Mol. Biosyst. 7, 2196-2204.
9. Bazwinsky-Wutschke, I., Wolgast, S., Muhlbauer, E., and Peschke, E. (2010). Distribution patterns of calcium-binding proteins in pancreatic tissue of non-diabetic as well as type 2 diabetic rats and in rat insulinoma beta-cells (INS-1). Histochem. Cell Biol. 134, 115-127.
10. Bitto, E., Bingman, C. A., Bittova, L., Frederick, R. O., Fox, B. G., and Phillips, G. N. Jr. (2009). X-ray structure of Danio rerio secretagogin: a hexa-EF-hand calcium sensor. Proteins 76, 477-483.
11. Braunewell, K. H. (2005). The darker side of Ca2+ signaling by neuronal Ca2+-sensor proteins: from Alzheimer's disease to cancer. Trends Pharmacol. Sci. 26, 345-351.
12. Brewer, G. J., Torricelli, J. R., Evege, E. K., and Price, P. J. (1993). Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576.
13. Burgoyne, R. D., and Haynes, L. P. (2012). Understanding the physiological roles of the neuronal calcium sensor proteins. Mol. Brain 5, 2.
14. Camandola, S., and Mattson, M. P. (2011). Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim. Biophys. Acta 1813, 965-973.
15. Craft, S., and Watson, G. S. (2004). Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3, 169-178.
16. Demuro, A., Parker, I., and Stutzmann, G. E. (2010). Calcium signaling and amyloid toxicity in Alzheimer disease. J. Biol. Chem. 285, 12463-12468.
17. Dityatev, A., and Rusakov, D. A. (2011). Molecular signals of plasticity at the tetrapartite synapse. Curr. Opin. Neurobiol. 21, 353-359.
18. Gartner, W., Lang, W., Leutmetzer, F., Domanovits, H., Waldhausl, W., and Wagner, L. (2001). Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca(2+)-binding protein. Cereb. Cortex 11, 1161-1169.
19. Gartner, W., Vila, G., Daneva, T., Nabokikh, A., Koc-Saral, F., Ilhan, A., Majdic, O., Luger, A., and Wagner, L. (2007). New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog. Am. J. Physiol. Metab. 293, E347-E354.
20. Hermes, M., Eichhoff, G., and Garaschuk, O. (2010). Intracellular calcium signalling in Alzheimer's disease. J. Cell. Mol. Med. 14, 30-41.
21. Hikosaka, O. (2010). The habenula: from stress evasion to value-based decision-making. Nat. Rev. Neurosci. 11, 503-513.
22. Ilhan, A., Neziri, D., Maj, M., Mazal, P. R., Susani, M., Base, W., Gartner, W., and Wagner, L. (2011). Expression of secretagogin in clear-cell renal cell carcinomas is associated with a high metastasis rate. Hum. Pathol. 42, 641-648.
23. Klausberger, T., Magill, P. J., Marton, L. F., Roberts, J. D., Cobden, P. M., Buzsaki, G., and Somogyi, P. (2003). Brain-state and cell-type-specific firing of hippocampal interneurons in vivo. Nature 421, 844-848.
24. Lai, M., Lu, B., Xing, X., Xu, E., Ren, G., and Huang, Q. (2006). Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A. Virchows Arch. 449, 402-409.
25. Maj, M., Gartner, W., Ilhan, A., Neziri, D., Attems, J., and Wagner, L. (2010). Expression of TAU in insulinsecreting cells and its interaction with the calcium-binding protein secretagogin. J. Endocrinol. 205, 25-36.
26. Mikhaylova, M., Hradsky, J., and Kreutz, M. R. (2011). Between promiscuity and specificity: novel roles of EF hand calcium sensors in neuronal Ca2+ signalling. J. Neurochem. 118, 695-713.
27. Mulder, J., Spence, L., Tortoriello, G., Dinieri, J. A., Uhlen, M., Shui, B., Kotlikoff, M. I., Yanagawa, Y., Aujard, F., Hokfelt, T., Hurd, Y. L., and Harkany, T. (2010). Secretagogin is a Ca2+-binding protein identifying prospective extended amygdala neurons in the developing mammalian telencephalon. Eur. J. Neurosci. 31, 2166-2177.
28. Mulder, J., Zilberter, M., Spence, L., Tortoriello, G., Uhlen, M., Yanagawa, Y., Aujard, F., Hokfelt, T., and Harkany, T. (2009). Secretagogin is a Ca2+-binding protein specifying subpopulations of telencephalic neurons. Proc. Natl. Acad. Sci. U.S.A. 106, 22492-22497.
29. Niggli, E., and Shirokova, N. (2007). A guide to sparkology: the taxonomy of elementary cellular Ca2+ signaling events. Cell Calcium 42, 379-387.
30. Rogstam, A., Linse, S., Lindqvist, A., James, P., Wagner, L., and Berggard, T.(2007).Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem. J.401, 353-363.
31. Rulifson, E. J., Kim, S. K., and Nusse, R. (2002). Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 296, 1118-1120
32. Schmidt, H.(2012). Three functional facets of calbindin D-28k. Front.Mol. Neurosci.5:25. doi:10.3389/fnmol.2012.00025
33. Schwaller, B. (2009). The continuing disappearance of "pure" Ca2+ buffers. Cell. Mol. Life Sci. 66, 275-300.
34. Skovhus, K. V., Bergholdt, R., Erichsen, C., Sparre, T., Nerup, J., Karlsen, A. E., and Pociot, F. (2006). Identification and characterization of secretagogin promoter activity. Scand. J. Immunol. 64, 639-645.
35. Steiner, J., Bogerts, B., Schroeter, M. L., and Bernstein, H. G. (2011). S100B protein in neurodegenerative disorders. Clin. Chem. Lab. Med. 49, 409-424.
36. Unger, J. W., Livingston, J. N., and Moss, A. M. (1991). Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog. Neurobiol. 36, 343-362.
37. Vasiljevic, M., Heisler, F. F., Hausrat, T. J., Fehr, S., Milenkovic, I., Kneussel, M., and Sieghart, W. (2011). Spatiotemporal expression analysis of the calcium-binding protein calumenin in the rodent brain. Neuroscience 202, 29-41.
38. Wagner, L., Oliyarnyk, O., Gartner, W., Nowotny, P., Groeger, M., Kaseer, K., Waldhausl, W., and Pasternack, M. S. (2000). Cloning and expression of secretagogin, a novel neuroendocrine and pancreatic islet of Langerhans-specific Ca2+-binding protein. J. Biol. Chem. 275, 24740-24751.
39. Yanez, M., Gil-Longo, J., and Campos-Toimil, M. (2012). Calcium binding proteins. Adv. Exp. Med. Biol. 740, 461-482.
40. Yu, J. T., Chang, R. C., and Tan, L. (2009). Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities. Prog. Neurobiol. 89, 240-255.
41. Zhao, W. Q., and Alkon, D. L. (2001). Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177, 125-134.
42. Zurek, J., and Fedora, M. (2012). The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir. (Wien) 154, 93-103.